logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Napoleone Ferrara

USPTO Granted Patents = 104 

 

 

Average Co-Inventor Count = 3.8

ph-index = 19

Forward Citations = 1,474(Granted Patents)

Forward Citations (Not Self Cited) = 1,372(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Belvedere, CA (US) (1994 - 2005)
  • South San Francisco, CA (US) (2014)
  • San Francisco, CA (US) (1996 - 2016)
  • La Jolla, CA (US) (2016 - 2022)
  • San Diego, CA (US) (2022 - 2023)

Company Filing History:

goldMedal92 out of 3,223 
 
Genentech, Inc.
 patents
silverMedal6 out of 98 
 
Genetech, Inc.
 patents
bronzeMedal5 out of 15,502 
 
University of California
 patents
4. 1 out of 11 
 
St. Elizabeth's Medical Center of Boston, Inc.
 patents
5. 1 out of 168 
 
F. Hoffmann-la Roche Ag
 patents
where one patent can have more than one assignee

Years Active: 1994-2023

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Vegf Inhibitors
Anti-Vegf Agents
Angiogenic Disorders
Vascular Endothelial Growth Factor
Anti-Bv8 Antibodies
Hematopoietic Activity
Angiopoietin-Like Proteins
Eg-Vegf Nucleic Acids
Transgenic Mice
Humanized Antibodies
Polypeptides Homologous To Vegf
Liver Growth Protection
104 patents (USPTO):Explore Patents
1. 11576948 - Long-acting VEGF inhibitors for intraocular neovascularization (2023-02-14),
2. 11524053 - Methods and compositions for treatment of angiogenic disorders using anti-VEGF agents (2022-12-13),
3. 11433118 - Long-acting VEGF inhibitors for intraocular neovascularization (2022-09-06),
4. 11382955 - Long-acting VEGF inhibitors for intraocular neovascularization (2022-07-12),
5. 9273113 - Methods of inhibiting vascular endothelial growth factor activity (2016-03-01),
6. 9266948 - Anti-Bv8 antibodies and uses thereof (2016-02-23),
7. 8858936 - Compositions with hematopoietic and immune activity (2014-10-14),
8. 8771685 - Anti-BV8 antibodies and uses thereof (2014-07-08),
9. 8604185 - Inhibitors of angiopoietin-like 4 protein, combinations, and their use (2013-12-10),
10. 8557238 - EG-VEGF nucleic acids and polypeptides and methods of use (2013-10-15),
11. 8541376 - Composition comprising and method of using angiopoietin-like protein 3 ANGPTL3 (2013-09-24),
12. 8287873 - Vascular endothelial cell growth factor antagonists and uses thereof (2012-10-16),
13. 8273353 - Inhibitors of vascular endothelial growth factor activity (2012-09-25),
14. 8268591 - Compositions and methods for producing inhibitors of vascular endothelial growth factor activity (2012-09-18),
15. 8268313 - Methods for using inhibitors of vascular endothelial growth factor activity (2012-09-18),

Title: The Innovative Journey of Inventor Napoleone Ferrara

Introduction: Inventor Napoleone Ferrara, a distinguished figure in the field of biotechnology and medical research, has made significant contributions to the world through his groundbreaking inventions and discoveries. Born in San Francisco, CA (US), Ferrara's work has revolutionized the way we approach healthcare and disease treatment.

Latest Patents: Ferrara holds several patents in the field of biotechnology and medical research, including patents related to novel drug delivery systems, innovative treatment methods for various diseases, and cutting-edge medical devices aimed at improving patient outcomes.

Career Highlights: With a career spanning several decades, Ferrara has held key positions in renowned research institutions and biotechnology companies. He is known for his pivotal role in the development of anti-angiogenic therapy, which has transformed the treatment of cancer and other diseases. Ferrara's research has led to the development of life-saving drugs that have had a profound impact on patient care worldwide.

Collaborations: Throughout his career, Ferrara has collaborated with leading scientists, researchers, and healthcare professionals to further the boundaries of medical innovation. His collaborative efforts have resulted in groundbreaking discoveries and advancements in the field of biotechnology, cementing his reputation as a visionary inventor.

Conclusion: Inventor Napoleone Ferrara's relentless pursuit of innovation and his unwavering commitment to improving healthcare have solidified his position as a trailblazer in the field of biotechnology. His groundbreaking inventions and contributions continue

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…